During the past decade, Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Avexa" with 1 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "Genmab" with 1 trials sponsored and "Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology" are "Breast Cancer" (4 trials), "Covid19" (1 trials), "HIV Infections" (1 trials), "Head and Neck Cancer" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology" are "Drug" (10 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Pertuzumab" (2 trials), "Trastuzumab" (2 trials), "trastuzumab emtansine" (2 trials) and "40 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".